Genmab A (GNMSF) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $26.0 million.
- Genmab A's Other Gross PP&E Adjustments rose 18888.89% to $26.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.0 million, marking a year-over-year increase of 18888.89%. This contributed to the annual value of $26.0 million for FY2025, which is 18888.89% up from last year.
- Genmab A's Other Gross PP&E Adjustments amounted to $26.0 million in Q4 2025, which was up 18888.89% from $24.0 million recorded in Q3 2025.
- Genmab A's 5-year Other Gross PP&E Adjustments high stood at $40.0 million for Q4 2023, and its period low was $9.0 million during Q4 2024.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was $25.0 million (2025), whereas its average is $24.2 million.
- As far as peak fluctuations go, Genmab A's Other Gross PP&E Adjustments tumbled by 7750.0% in 2024, and later soared by 18888.89% in 2025.
- Quarter analysis of 3 years shows Genmab A's Other Gross PP&E Adjustments stood at $40.0 million in 2023, then crashed by 77.5% to $9.0 million in 2024, then surged by 188.89% to $26.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at $26.0 million for Q4 2025, versus $24.0 million for Q3 2025 and $27.0 million for Q2 2025.